Assessment of molecular markers of clinical sensitivity to single-agent taxane therapy for metastatic breast cancer Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Phytogenic
  • Biomarkers, Tumor
  • Breast Neoplasms
  • Paclitaxel

abstract

  • The IHC biomarkers studied were not predictive of response to single-agent taxane chemotherapy in patients with metastatic breast cancer. Identification of molecular correlates of taxane response remains an important goal.

publication date

  • May 2002

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2002.08.125

PubMed ID

  • 11981003

Additional Document Info

start page

  • 2319

end page

  • 26

volume

  • 20

number

  • 9